Contractor
AMNEAL PHARMACEUTICALS OF NEW YORK, LLC
BROOKHAVEN, NY
- UEI
- LVEBAQTPN615
- Parent UEI
- LVEBAQTPN615
- Resolved by
- uei
- Confidence
- 1.000
Obligated to date
$492,4881
Awards
4
Agencies served
1
Active from Jun 23, 2022 to Oct 19, 2026.
Sign in to watchRecent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79722D0161 65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD | Department of Veterans Affairs | — | Jun 23, 2022 | — |
| 36E79726A0013 BPA FOR BREKIYA | Department of Veterans Affairs | — | Apr 20, 2026 | — |
| 36C26025F0044 XYREM (SODIUM OXYBATE) ORAL SOLUTION. | Department of Veterans Affairs | MO | Apr 2, 2026 | $173,089 |
| 36C26026F0059 PHARMACEUTICAL - XYREM (SODIUM OXYBATE) - 2026 PRICE INCREASE & DOSAGE USED. | Department of Veterans Affairs | NY | Mar 6, 2026 | $319,399 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier LVEBAQTPN615, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Oct 21, 2026.